Defective Medical Devices
Defective medical devices can cause injury and harm to unknowing patients. Medical device users expect treatments to work effectively and safely without undue risk or harm. Independent institutions, such as the Food and Drug Administration (FDA), place medical devices through extensive testing before releasing them to the consumer market. If potential risks and side effects are found, they are documented thoroughly and the user of the medical device is informed of any potential detriment to their health.
Regardless of this testing, medical devices are sometimes found to be faulty under certain circumstances or to raise the overall chance of illness or injury. The Guidant Defibrillator is one example of a defective medical device. Once installed, some models of the defibrillator run the risk of causing serious injury to the patient at an unknown time. Dealing with the risks associated with a defective medical device can have life-altering consequences.
In the event a defective medical device causes injury or death, the manufacturers of the device may be held legally liable for marketing a dangerous product. Some legal actions associated with defective medical devices evolve into class action or mass tort suits, whereby those affected by the hazardous devices can make a personal injury claim for a predetermined amount of compensation.
If you or a loved one has suffered an injury, illness, or death due to a defective medical device, call VanDerGinst Law at 1-866-843-7367 or click here for a FREE online case evaluation. The initial consultation is free of charge. If we agree to handle your injury case, we will work on a contingency fee basis, which means we get paid for our services only if, and when, there is a money recovery for you. In many cases a lawsuit must be filed before an applicable expiration date, known as a statute of limitations. So please call right away to ensure that you do not waive your right to possible compensation.
Defective Medical Devices
Links on the Web
 MedWatch Safety Alert RSS FeedFDA MedWatch Safety Alerts |
| Thu, 18 Mar 2010 13:45:00 -0400 Becton, Dickinson (BD) Q-Syte Luer Access Split Septum Device: Class I Recall Defective devices may result in air bubbles leaking into the infusion system and into the patient?s bloodstream. Click here to read this Defective Medical Devices news article. |
| Wed, 17 Mar 2010 00:00:00 -0400 Gyrus ACMI Micron Bobbin Vent Tube T: Class I Recall Device implanted for ventilation or drainage of the middle ear - shipped without being sterilized. Click here to read this Defective Medical Devices news article. |
| Wed, 17 Mar 2010 00:00:00 -0400 Cleviprex (clevidipine butyrate): Recall The recall of 12/2009 has been expanded to include four additional lots. Presence of particulate matter which could potentially reduce blood flow in capillaries, cause mechanical damage to some tissues, or initiate acute or chronic inflammatory reactions. Click here to read this Defective Medical Devices news article. |
| Tue, 16 Mar 2010 08:50:00 -0400 Teleflex Arrow IV Tubing Sets, Accessories, and Embolectomy Catheters: Recall Product sterility cannot be guaranteed. Testing revealed pin holes in some of the pouches in which the products are packaged. Click here to read this Defective Medical Devices news article. |
| Fri, 12 Mar 2010 15:00:00 -0500 Plavix (clopidogrel): Reduced effectiveness in patients who are poor metabolizers of the drug Boxed warning added regarding reduced effectiveness of Plavix in poor metabolizers. Click here to read this Defective Medical Devices news article. |
| Fri, 12 Mar 2010 13:00:00 -0500 Counterfeit Polypropylene Surgical Mesh: Initial Communication Various sizes of counterfeit flat sheets of polypropylene surgical mesh are being marketed in the United States labeled with the C. R. Bard/Davol brand name. Click here to read this Defective Medical Devices news article. |
| National Institutes of Health (NIH) News Releases News Releases from the National Institutes of Health (NIH) |
| Thu, 18 Mar 2010 12:36:00 EDT NHGRI Launches Genomic Careers Resource for Students To help students planning their professional careers understand the opportunities in the fields of genetics and genomics, the National Human Genome Research Institute (NHGRI) today launched the Genomic Careers Resource on the institute's Web site, www.genome.gov. The careers resource showcases nearly 50 career opportunities through video interviews, career profiles, tools to rate potential career choices, and an interactive game. Click here to read this Defective Medical Devices news article. |
| Thu, 18 Mar 2010 10:01:00 EDT NIH Announces Genetic Testing Registry The National Institutes of Health announced today that it is creating a public database that researchers, consumers, health care providers, and others can search for information submitted voluntarily by genetic test providers. The Genetic Testing Registry (GTR) aims to enhance access to information about the availability, validity, and usefulness of genetic tests. Click here to read this Defective Medical Devices news article. |
| Thu, 18 Mar 2010 09:01:00 EDT Adding Common Genetic Variants to Breast Cancer Risk Models Offers Only Small Benefit Scientists report that breast cancer risk assessment models, which predict a woman's chance of developing breast cancer, do not perform better when they include common inherited genetic variants recently linked to the disease. Therefore, recommendations for breast cancer screening or treatments will remain unchanged for most women. The study, led by investigators from the National Cancer Institute (NCI), part of the National Institutes of Health, appears in the March 18, 2010, New England Journal of Medicine. Click here to read this Defective Medical Devices news article. |
| Wed, 17 Mar 2010 12:06:00 EDT NIH Clinical Center to Open State-of-the-Art Pharmaceutical Development Facility Members of the media are invited to tour the new one-of-a-kind National Institutes of Health Clinical Center pharmaceutical development facility. Originally established in 1956, the resource enables NIH intramural researchers to design studies with tailored drug treatment. Facility staff manage, analyze, and create experimental medications and vaccines used in clinical research studies at the Clinical Center, NIH's clinical research hospital. Click here to read this Defective Medical Devices news article. |
| Tue, 16 Mar 2010 09:51:00 EDT Bench to Bassinet Program Seeks Congenital Heart Disease Treatments To help speed the translation of scientific discoveries into usable treatments in congenital heart disease, the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health recently launched the Bench to Bassinet Program. This program, which involves several major research institutions across the country, will be highlighted in the March 23 edition of the Journal of the American College of Cardiology. Congenital heart disease affects the lives of 40,000 newborns a year in the United States, and up to 2 million adults are living with congenital heart disease. Click here to read this Defective Medical Devices news article. |
| Mon, 15 Mar 2010 15:51:00 EDT Statement of Anthony S. Fauci, M.D., Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, on National Native HIV/AIDS Awareness Day, March 20, 2010 On National Native HIV/AIDS Awareness Day, the National Institute of Allergy and Infectious Diseases (NIAID), part of NIH, joins American Indians, Alaska Natives and Native Hawaiians in remembering those who have succumbed to HIV/AIDS. We at NIAID reaffirm our commitment on this occasion to the goal of controlling and ultimately ending this devastating pandemic. Click here to read this Defective Medical Devices news article. |
